HAVCR1 and cancer: Using plasma samples from the European Prospective Investigation into Cancer and Nutrition, Scelo et al. [11] reported that serum KIM‐1 levels could predict RCC incidence up to 5 years before diagnosis and were associated with a higher risk of death.